Eight talks, a debate on first-line ES-SCLC and a panel on patient cases from the audience: ctDNA, targeted therapy, ADCs, early-stage IO and TCEs in SCLC, in one day.

That is the International Lung Cancer Summit (ILCS) 2026, chaired by Solange Peters (@peters_solange) and ), in Lausanne on Friday 13 November and live online. Here is the trailer. Registration is free for healthcare professionals. We would be glad to see you at CHUV, and just as glad to see you on the stream 🙂

ILCS 2026 faculty: @DasMillie11 @HHorinouchi @TelmaSequeiraMD @christine_lovly @dplanchard @PatelOncology @ACortelliniMD @g_mountzios @a_dingemans

Registration is open: lungsummit.org/registration/

#ILCS2026 #LungCancer #NSCLC #SCLC

The International Lung Cancer Summit (ILCS) 2026 starts tomorrow, 13 November, at 09:45 CET, with ctDNA first and the debate on first-line ES-SCLC at 16:00, at CHUV in Lausanne and online.

If you have not registered yet, there is still time today. See you tomorrow 🙂

ILCS 2026 e @Alfdoc2 @DasMillie11 @HHorinouchi @TelmaSequeiraMD @christine_lovly @dplanchard @PatelOncology @ACortelliniMD @g_mountzios @a_dingemans

Registration is open: lungsummit.org/registration/

#ILCS2026 #LungCancer #NSCLC #SCLC

Can't get to Lausanne on Friday? A free Lung Summit account lets you follow every session of the International Lung Cancer Summit (ILCS) 2026 live online, from 09:45 CET on 13 November.

If you have not registered yet, sign up today so your account is ready on Friday. We look ith us 🙂

ILCS 2026 faculty: @peters_solange @Alfdoc2 @DasMillie11 @HHorinouchi @TelmaSequeiraMD @christine_lovly @dplanchard @PatelOncology @ACortelliniMD @g_mountzios @a_dingemans

Registration is open: lungsummit.org/registration/

#ILCS2026 #LungCancer #NSCLC #SCLC

The International Lung Cancer Summit (ILCS) 2026 closes with a panel on patient cases sent in by the audience.

Alfredo Addeo (@Alfdoc2), of Geneva University Hospitals, chairs with Solange Peters (@peters_solange). Send a case at lungsummit.org/patient-cases, and join us on Friday in gistration is open: lungsummit.org/registration/

#ILCS2026 #LungCancer #NSCLC #SCLC

The International Lung Cancer Summit (ILCS) 2026 runs this Friday, 13 November, from 09:45 to 17:00 CET at CHUV in Lausanne and live online.

If a colleague is still deciding, please pass the flyer on. We look forward to welcoming you and your colleagues.

ILCS 2026 faculty: 2 @DasMillie11 @HHorinouchi @TelmaSequeiraMD @christine_lovly @dplanchard @PatelOncology @ACortelliniMD @g_mountzios @a_dingemans

Registration is open: lungsummit.org/registration/

#ILCS2026 #LungCancer #NSCLC #SCLC

🔥Join Us! #ILCS2026 @LungSummit
🗓️This Friday, 13 November, from 09:45 to 17:00 CET
🌍CHUV in Lausanne and Live Online
🌏Evening Timing in Asian Time Zones
🆙Updated A to Z of Lung Cancer in a Single Day
🗣️Highly Engaged, Fantastic Faculty
👥Twice as Much Time Allocated to cess: Onsite, Live Streaming, and On-demand
💰Free 🆓Registration for HCPs or Scientists
▶️Registration is open: lungsummit.org/registration/
#LCSM @OncoAlert

The International Lung Cancer Summit (ILCS) 2026 runs this Friday, 13 November, from 09:45 to 17:00 CET at CHUV in Lausanne and live online.

If a colleague is still deciding, please pass the flyer on. We look forward to welcoming you and your colleagues.

ILCS 2026 faculty: 2 @DasMillie11 @HHorinouchi @TelmaSequeiraMD @christine_lovly @dplanchard @PatelOncology @ACortelliniMD @g_mountzios @a_dingemans

Registration is open: lungsummit.org/registration/

#ILCS2026 #LungCancer #NSCLC #SCLC

Sponsors have no control over, or input into, the scientific content of the International Lung Cancer Summit (ILCS) 2026, and we thank them for the support that makes the day possible.

We meet in Lausanne and online this Friday, 13 November. Thank you to every sponsor, and to ered so far.

ILCS 2026 faculty: @peters_solange @Alfdoc2 @DasMillie11 @HHorinouchi @TelmaSequeiraMD @christine_lovly @dplanchard @PatelOncology @ACortelliniMD @g_mountzios @a_dingemans

Registration is open: lungsummit.org/registration/

#ILCS2026 #LungCancer #NSCLC #SCLC

Many decisions in clinic fall outside what the trials tested, and the International Lung Cancer Summit (ILCS) 2026 closes on them, with a panel on patient cases sent in by the audience at 16:35 CET.

Send yours at lungsummit.org/patient-cases, without anything that could identify the (@peters_solange) and Alfredo Addeo (@Alfdoc2) chair, in Lausanne and online on 13 November. We hope to see your case on the screen 🙂

ILCS 2026 faculty: @DasMillie11 @HHorinouchi @TelmaSequeiraMD @christine_lovly @dplanchard @PatelOncology @ACortelliniMD @g_mountzios @a_dingemans

Registration is open: lungsummit.org/registration/

#ILCS2026 #LungCancer #NSCLC #SCLC

ctDNA and molecular testing, targeted therapy, ADCs, IO around surgery and new options in SCLC: the International Lung Cancer Summit (ILCS) 2026 covers them in a day, next Friday, 13 November.

Come to CHUV in Lausanne, or follow live online from 09:45 CET. We hope you can join : @peters_solange @Alfdoc2 @DasMillie11 @HHorinouchi @TelmaSequeiraMD @christine_lovly @dplanchard @PatelOncology @ACortelliniMD @g_mountzios @a_dingemans

Registration is open: lungsummit.org/registration/

#ILCS2026 #LungCancer #NSCLC #SCLC

Three days to go: NSCLC and SCLC in one day, from ctDNA to TCEs.

Solange Peters (@peters_solange), of CHUV, chairs the International Lung Cancer Summit (ILCS) 2026 with Alfredo Addeo (@Alfdoc2), this Friday, 13 November, in Lausanne and online, from 09:45 CET.

Registration is ERXFP4

#ILCS2026 #LungCancer #NSCLC #SCLC

Sponsors have no control over, or input into, the scientific content of the International Lung Cancer Summit (ILCS) 2026, and we thank them for the support that makes the day possible.

We meet in Lausanne and online this Friday, 13 November. Thank you to every sponsor, and to ered so far.

ILCS 2026 faculty: @peters_solange @Alfdoc2 @DasMillie11 @HHorinouchi @TelmaSequeiraMD @christine_lovly @dplanchard @PatelOncology @ACortelliniMD @g_mountzios @a_dingemans

Registration is open: lungsummit.org/registration/

#ILCS2026 #LungCancer #NSCLC #SCLC

Really enjoyed being part of the @ESOncology Multidisciplinary Masterclass in Oncology in Venice!
And what a setting! San Servolo Island was a special place for a retreat dedicated to education and science, with Venice as the backdrop.
Big thanks to ESO, all the lung cancer cbertolaccini @fede_pezz86 Csaba Polgar and participants for making it such a great experience!
@PoliclinCampus
@CampusBioMedico
@ImperialSandC
@IASLC
@LungSummit
#ESO #Oncology #MedicalEducation

Incredibly honored to be invited by @TonyMok9 and the Chinese University of #HongKong @CUHKofficial @CUHKMedicine to deliver a lecture on DLL3-targeted treatments in #SCLC .
And incredibly grateful for this amazing family of Asian friends and their marvellous hospitality ! @stephanieplsaw
@ThomasW35874311 @danieltanmd

Proud to support @RManochakian in his candidacy for the #ASCO Nominating Committee! An outstanding colleague and a dedicated leader with a strong commitment to our oncology community. Wishing you every success, Rami! 👏

Badge holders meet in the Agora building at CHUV, and online-pass and free-account holders log in on lungsummit.org: the International Lung Cancer Summit (ILCS) 2026 is a week from today, 13 November, from 09:45 CET in Lausanne.

The day is CME-accredited by SSMO and registered yet, do it this week so your account is ready on the day. See you next Friday 🙂

ILCS 2026 faculty: @peters_solange @Alfdoc2 @DasMillie11 @HHorinouchi @TelmaSequeiraMD @christine_lovly @dplanchard @PatelOncology @ACortelliniMD @g_mountzios @a_dingemans

Registration is open: lungsummit.org/registration/

#ILCS2026 #LungCancer #NSCLC #SCLC

At the International Lung Cancer Summit (ILCS), experts talk through what each of them actually does for a given patient, and why, in front of an international audience that sees where practice differs and how much is shared.

Hossein Borghaei (@HosseinBorghaei, @FoxChaseCancer) one of those” meetings where the interaction goes beyond the slides. We filmed him at the @etop_ibcsg workshop in Zurich.

ILCS 2026 is on 13 November at the CHUV in Lausanne, with 10 CME credits.

An awesome group of experts gathered at our first RAS-Workshop in Zurich the last two days, giving an overview of the underlying biology, the current landscape of RAS inhibitors, emerging patterns in toxicity, current trials and strategies in the fields of NSCLC, CRC and PDAC.

At the International Lung Cancer Summit (ILCS), experts talk through what each of them actually does for a given patient, and why, in front of an international audience that sees where practice differs and how much is shared.

Hossein Borghaei (@HosseinBorghaei, @FoxChaseCancer) one of those” meetings where the interaction goes beyond the slides. We filmed him at the @etop_ibcsg workshop in Zurich.

ILCS 2026 is on 13 November at the CHUV in Lausanne, with 10 CME credits.

Badge holders meet in the Agora building at CHUV, and online-pass and free-account holders log in on lungsummit.org: the International Lung Cancer Summit (ILCS) 2026 is a week from today, 13 November, from 09:45 CET in Lausanne.

The day is CME-accredited by SSMO and registered yet, do it this week so your account is ready on the day. See you next Friday 🙂

ILCS 2026 faculty: @peters_solange @Alfdoc2 @DasMillie11 @HHorinouchi @TelmaSequeiraMD @christine_lovly @dplanchard @PatelOncology @ACortelliniMD @g_mountzios @a_dingemans

Registration is open: lungsummit.org/registration/

#ILCS2026 #LungCancer #NSCLC #SCLC

Martin Reck (@MartinReck2) presented MDT-BRIDGE at ESMO 2026, where 3 in 4 patients with resectable or borderline resectable NSCLC reached resection after neoadjuvant durvalumab plus chemotherapy. Among the authors are our faculty members Nicolas Girard (@nicogirardcurie) and ricFili).

🔬 MDT-BRIDGE: neoadjuvant durvalumab plus chemotherapy in resectable or borderline resectable NSCLC, n=142
📊 Resection rate 74.6% (descriptive)
📊 R0 resection 96.2% (of resected patients)
⚠️ Gr 3-4 AEs, adjuvant vs consolidation phase 7.4% vs 17.4%
⚠️ Descriptive primary endpoint, with no formal hypothesis test

Compare the surgery and chemoradiotherapy pathways in our article.

@myESMO

lungsummit.org/articles/neoad…